The Medical Affairs and Healthcare Industry Chronicle

Patients and Pricing — the benefits of including patients in pricing discussions — insights from an ICER review — HTA roundtables

No pharma industry meeting agenda would be complete without the topics: patient-engagement, patient-centricity and oftentimes pricing.

Today’s installment of my recent interview with Suz Schrandt, Director of Patient Engagement at the Arthritis Foundation will focus on these topics and more. Including a key question:

What can pharma learn from car manufacturers?

In order to respect your mailbox and your time and to be compliant with GDPR, please reconfirm your subscription to this newsletter by clicking the link: update your preferences or if you don’t want to receive the newsletter anymore, please unsubscribe from this list.

Only subscribed individuals will receive the newsletter going forward.

Read on »

What pharma could learn from car manufacturers about patient engagement. Interview with Suz Schrandt, Director of Patient Engagement at the Arthritis Foundation

A common goal for teams in the healthcare industry is how to be more patient-centric. It’s an important question.

Putting patients at the center of everything we do sounds good. But how do you ensure that your plans will deliver on your promise?

Read on as I share some ideas from an interview with Suz Schrandt Director of Patient-Engagement at the Arthritis Foundation.

Yesterday, I interviewed Suz Schrandt, Director of Patient Engagement for the Arthritis Foundation.

Read on »

Five Hot Topics in Medical Affairs That Should Be On Your Radar for 2017

I recently got back from this year’s DIA Medical Affairs and Scientific Communications Forum.
It was a great trip. From the beautiful resort, the excellent agenda, to meeting old friends and new to presenting some survey data on collaboration. The grand finale on my trip home? Meeting an IT expert, who was happy to discuss IT systems in highly-regulated aviation, banking and insurance industries.

My only regret is that I couldn’t be at every presentation.

Read on »